ClinicalTrials.Veeva

Menu
A

Alta Pharmaceutical Research Center | Dunwoody, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ARO-APOC3
Obicetrapib
Apixaban
Bococizumab
TI-166
Triglycerides
TI-162
Pemafibrate
Anakinra
Insulin aspart

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Obicetrapib
Drug: Placebo

This is an open-label extension of the parent studies AROAPOC3-2001 and AROAPOC3-2002. Adult participants with dyslipidemia who completed the blinded...

Active, not recruiting
Dyslipidemias
Drug: ARO-APOC3

Trial sponsors

Arrowhead Pharmaceuticals logo
MannKind logo
N
Pfizer logo
Bayer logo
Bristol-Myers Squibb (BMS) logo
Kowa logo
Sobi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems